Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 3/2016

Open Access 01-03-2016 | Original Contribution

Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls

Authors: David Coghill, Paul Hodgkins

Published in: European Child & Adolescent Psychiatry | Issue 3/2016

Login to get access

Abstract

The impact of attention-deficit/hyperactivity disorder (ADHD) on health-related quality of life (HRQoL) is reported to be similar to that of other mental health and physical disorders. In this cross-sectional study, we hypothesized that children with ADHD and children with type 1 diabetes mellitus (T1DM) would have significantly worse HRQoL compared with healthy children, and that better clinical status in ADHD and T1DM would be associated with better HRQoL. Children were recruited from three outpatient services in Scotland. Responses to two frequently used validated HRQoL instruments, the Paediatric Quality of Life Inventory (PedsQL) and Child Health and Illness Profile-child edition (CHIP-CE), were obtained from parents/carers and children (6–16 years) with/without ADHD or T1DM. Child and parent/carer-completed HRQoL measurements were evaluated for 213 children with ADHD, 58 children with T1DM and 117 healthy children (control group). Significantly lower self and parent/carer ratings were observed across most PedsQL (P < 0.001) and CHIP-CE (P < 0.05) domains (indicating reduced HRQoL) for the ADHD group compared with the T1DM and control groups. Parent/carer and child ratings were significantly correlated for both measures of HRQoL (PedsQL total score: P < 0.001; CHIP-CE all domains: P < 0.001), but only with low-to-moderate strength. Correlation between ADHD severity and HRQoL was significant with both PedsQL and CHIP-CE for all parent/carer (P < 0.01) and most child (P < 0.05) ratings; more ADHD symptoms were associated with poorer HRQoL. These data demonstrate that ADHD has a significant impact on HRQoL (as observed in both parent/carer and child ratings), which seems to be greater than that for children with T1DM.
Literature
1.
go back to reference Leidy NK, Revicki DA, Geneste B (1999) Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2:113–117CrossRefPubMed Leidy NK, Revicki DA, Geneste B (1999) Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2:113–117CrossRefPubMed
2.
go back to reference Coghill D, Danckaerts M, Sonuga-Barke E, Sergeant J (2009) Practitioner review: quality of life in child mental health–conceptual challenges and practical choices. J Child Psychol Psychiatry 50:544–561CrossRefPubMed Coghill D, Danckaerts M, Sonuga-Barke E, Sergeant J (2009) Practitioner review: quality of life in child mental health–conceptual challenges and practical choices. J Child Psychol Psychiatry 50:544–561CrossRefPubMed
3.
go back to reference Danckaerts M, Sonuga-Barke EJ, Banaschewski T, Buitelaar J, Dopfner M, Hollis C, Santosh P, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Zuddas A, Coghill D (2010) The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 19:83–105PubMedCentralCrossRefPubMed Danckaerts M, Sonuga-Barke EJ, Banaschewski T, Buitelaar J, Dopfner M, Hollis C, Santosh P, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Zuddas A, Coghill D (2010) The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 19:83–105PubMedCentralCrossRefPubMed
4.
go back to reference Coghill D (2010) The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 24:843–866CrossRefPubMed Coghill D (2010) The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 24:843–866CrossRefPubMed
5.
go back to reference Brod M (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15:117–129CrossRefPubMed Brod M (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15:117–129CrossRefPubMed
6.
go back to reference Landgraf JM, Rich M, Rappaport L (2002) Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med 156:384–391CrossRefPubMed Landgraf JM, Rich M, Rappaport L (2002) Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med 156:384–391CrossRefPubMed
7.
go back to reference Landgraf JM (2007) Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord 11:352–361CrossRef Landgraf JM (2007) Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord 11:352–361CrossRef
8.
go back to reference Escobar R, Schacht A, Wehmeier PM, Wagner T (2010) Quality of life and attention-deficit/hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J Clin Psychopharmacol 30:145–151CrossRefPubMed Escobar R, Schacht A, Wehmeier PM, Wagner T (2010) Quality of life and attention-deficit/hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J Clin Psychopharmacol 30:145–151CrossRefPubMed
9.
go back to reference Coghill D (2011) Pragmatic measures in paediatric psychopharmacology–are we getting it right? Eur Neuropsychopharmacol 21:571–583CrossRefPubMed Coghill D (2011) Pragmatic measures in paediatric psychopharmacology–are we getting it right? Eur Neuropsychopharmacol 21:571–583CrossRefPubMed
10.
go back to reference Hodgkins P, Dittmann RW, Sorooshian S, Banaschewski T (2013) Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments. Exp Rev Neurother 13:425–433CrossRef Hodgkins P, Dittmann RW, Sorooshian S, Banaschewski T (2013) Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments. Exp Rev Neurother 13:425–433CrossRef
11.
go back to reference Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12–19CrossRefPubMed Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12–19CrossRefPubMed
12.
go back to reference Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948CrossRefPubMed Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948CrossRefPubMed
13.
go back to reference Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679CrossRefPubMed Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679CrossRefPubMed
14.
go back to reference Polanczyk G, Salum GA, Sugaya LS, Caye A, Rohde LA (2015) Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 56(3):345–365CrossRefPubMed Polanczyk G, Salum GA, Sugaya LS, Caye A, Rohde LA (2015) Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 56(3):345–365CrossRefPubMed
15.
16.
go back to reference Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 7351:429–433CrossRef Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 7351:429–433CrossRef
17.
go back to reference Cussen A, Sciberras E, Ukoumunne OC, Efron D (2012) Relationship between symptoms of attention-deficit/hyperactivity disorder and family functioning: a community-based study. Eur J Pediatr 171:271–280CrossRefPubMed Cussen A, Sciberras E, Ukoumunne OC, Efron D (2012) Relationship between symptoms of attention-deficit/hyperactivity disorder and family functioning: a community-based study. Eur J Pediatr 171:271–280CrossRefPubMed
18.
go back to reference Coghill D, Soutullo C, d’Aubuisson C, Preuss U, Lindback T, Silverberg M, Buitelaar J (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health 2:31PubMedCentralCrossRefPubMed Coghill D, Soutullo C, d’Aubuisson C, Preuss U, Lindback T, Silverberg M, Buitelaar J (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health 2:31PubMedCentralCrossRefPubMed
19.
go back to reference Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723PubMedCentralCrossRefPubMed Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723PubMedCentralCrossRefPubMed
20.
go back to reference Velo S, Kereszteny A, Szentivanyi D, Balazs J (2013) Quality of life of patients with attention-deficit/hyperactivity disorder: systematic review of the past 5 years. Neuropsychopharmacol Hung 15:73–82PubMed Velo S, Kereszteny A, Szentivanyi D, Balazs J (2013) Quality of life of patients with attention-deficit/hyperactivity disorder: systematic review of the past 5 years. Neuropsychopharmacol Hung 15:73–82PubMed
21.
go back to reference Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I (2005) Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 116:e364–e369CrossRefPubMed Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I (2005) Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 116:e364–e369CrossRefPubMed
22.
go back to reference Limbers CA, Ripperger-Suhler J, Heffer RW, Varni JW (2011) Patient-reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in pediatric patients with attention-deficit/hyperactivity disorder and comorbid psychiatric disorders: feasibility, reliability, and validity. Value Health 14:521–530CrossRefPubMed Limbers CA, Ripperger-Suhler J, Heffer RW, Varni JW (2011) Patient-reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in pediatric patients with attention-deficit/hyperactivity disorder and comorbid psychiatric disorders: feasibility, reliability, and validity. Value Health 14:521–530CrossRefPubMed
23.
go back to reference Holling H, Schlack R, Dippelhoffer A, Kurth BM (2008) Personal, familial and social resources and health-related quality of life in children and adolescents with chronic conditions]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:606–620CrossRefPubMed Holling H, Schlack R, Dippelhoffer A, Kurth BM (2008) Personal, familial and social resources and health-related quality of life in children and adolescents with chronic conditions]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:606–620CrossRefPubMed
25.
go back to reference Xiang YT, Luk ES, Lai KY (2009) Quality of life in parents of children with attention-deficit-hyperactivity disorder in Hong Kong. Aust N Z J Psychiatry 43:731–738CrossRefPubMed Xiang YT, Luk ES, Lai KY (2009) Quality of life in parents of children with attention-deficit-hyperactivity disorder in Hong Kong. Aust N Z J Psychiatry 43:731–738CrossRefPubMed
26.
go back to reference Ahola AJ, Saraheimio M, Forsblom C, Hietala K, Sintonen H, Groop PH, FinnDiane Study Group (2010) Health-related quality of life in patients with type 1 diabetes—association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant 25:1903–1908CrossRefPubMed Ahola AJ, Saraheimio M, Forsblom C, Hietala K, Sintonen H, Groop PH, FinnDiane Study Group (2010) Health-related quality of life in patients with type 1 diabetes—association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant 25:1903–1908CrossRefPubMed
27.
go back to reference Graue M, Wentzel-Larsen T, Hanestad BR, Batsvik B, Sovik O (2003) Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments. Acta Paediatr 92:1190–1196CrossRefPubMed Graue M, Wentzel-Larsen T, Hanestad BR, Batsvik B, Sovik O (2003) Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments. Acta Paediatr 92:1190–1196CrossRefPubMed
28.
go back to reference Kalyva E, Malakonaki E, Eiser C, Mamoulakis D (2011) Health-related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions. Pediatr Diabetes 12:34–40CrossRefPubMed Kalyva E, Malakonaki E, Eiser C, Mamoulakis D (2011) Health-related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions. Pediatr Diabetes 12:34–40CrossRefPubMed
29.
go back to reference Varni JW, Burwinkle TM (2006) The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: a population-based study. Health Qual Life Outcomes 4:26PubMedCentralCrossRefPubMed Varni JW, Burwinkle TM (2006) The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: a population-based study. Health Qual Life Outcomes 4:26PubMedCentralCrossRefPubMed
30.
go back to reference Riley AW, Forrest CB, Rebok GW, Starfield B, Green BF, Robertson JA, Friello P (2004) The Child Report Form of the CHIP-Child Edition: reliability and validity. Med Care 42:221–231CrossRefPubMed Riley AW, Forrest CB, Rebok GW, Starfield B, Green BF, Robertson JA, Friello P (2004) The Child Report Form of the CHIP-Child Edition: reliability and validity. Med Care 42:221–231CrossRefPubMed
31.
go back to reference Riley AW, Forman EM, Starfield B, Rebok GW, Robertson JA, Green BF (2004) The Parent Report Form of the CHIP-Child Edition: reliability and validity. Med Care 42:210–220CrossRefPubMed Riley AW, Forman EM, Starfield B, Rebok GW, Robertson JA, Green BF (2004) The Parent Report Form of the CHIP-Child Edition: reliability and validity. Med Care 42:210–220CrossRefPubMed
32.
go back to reference Upton P, Eiser C, Cheung I, Hutchings HA, Jenney M, Maddocks A, Russell IT, Williams JG (2005) Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes 3:22PubMedCentralCrossRefPubMed Upton P, Eiser C, Cheung I, Hutchings HA, Jenney M, Maddocks A, Russell IT, Williams JG (2005) Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes 3:22PubMedCentralCrossRefPubMed
33.
go back to reference Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G (2006) Validity of the health-related quality of life assessment in the ADORE study: parent Report Form of the CHIP-Child Edition. Eur Child Adolesc Psychiatry 15(Suppl 1):I63–I71CrossRefPubMed Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G (2006) Validity of the health-related quality of life assessment in the ADORE study: parent Report Form of the CHIP-Child Edition. Eur Child Adolesc Psychiatry 15(Suppl 1):I63–I71CrossRefPubMed
34.
go back to reference Riley AW, Spiel G, Coghill D, Dopfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ (2006) Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15(Suppl 1):I38–I45CrossRefPubMed Riley AW, Spiel G, Coghill D, Dopfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ (2006) Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15(Suppl 1):I38–I45CrossRefPubMed
36.
go back to reference DuPaul G, Power T, Anastopoulos A, Reed R (1998) The ADHD rating scale IV checklist, norms and clinical interpretation. Guilford Press, New York DuPaul G, Power T, Anastopoulos A, Reed R (1998) The ADHD rating scale IV checklist, norms and clinical interpretation. Guilford Press, New York
37.
go back to reference American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation (2007) Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 50:2042–2043CrossRef American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation (2007) Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 50:2042–2043CrossRef
39.
go back to reference Winer DJ, Brown DR, Michels KM (1991) Statistical principles in experimental design. McGraw-Hill, New York Winer DJ, Brown DR, Michels KM (1991) Statistical principles in experimental design. McGraw-Hill, New York
40.
go back to reference Irwin DE, Gross HE, Stucky BD, Thissen D, DeWitt EM, Lai JS, Amtmann D, Khastou L, Varni JW, DeWalt DA (2012) Development of six PROMIS pediatrics proxy-report item banks. Health Qual Life Outcomes 10:22PubMedCentralCrossRefPubMed Irwin DE, Gross HE, Stucky BD, Thissen D, DeWitt EM, Lai JS, Amtmann D, Khastou L, Varni JW, DeWalt DA (2012) Development of six PROMIS pediatrics proxy-report item banks. Health Qual Life Outcomes 10:22PubMedCentralCrossRefPubMed
41.
go back to reference Fliers EA, Buitelaar JK, Maras A, Bul K, Hohle E, Faraone SV, Franke B, Rommelse NN (2013) ADHD is a risk factor for overweight and obesity in children. J Dev Behav Pediatr 34:566–574CrossRefPubMed Fliers EA, Buitelaar JK, Maras A, Bul K, Hohle E, Faraone SV, Franke B, Rommelse NN (2013) ADHD is a risk factor for overweight and obesity in children. J Dev Behav Pediatr 34:566–574CrossRefPubMed
42.
go back to reference Kwon HJ, Lee MY, Ha M, Yoo SJ, Paik KC, Lim JH, Sakong J, Lee CG, Kang DM, Hong SJ, Cho HI, Lim MH (2014) The associations between ADHD and asthma in Korean children. BMC Psychiatry 14:70PubMedCentralCrossRefPubMed Kwon HJ, Lee MY, Ha M, Yoo SJ, Paik KC, Lim JH, Sakong J, Lee CG, Kang DM, Hong SJ, Cho HI, Lim MH (2014) The associations between ADHD and asthma in Korean children. BMC Psychiatry 14:70PubMedCentralCrossRefPubMed
43.
go back to reference Rajmil L, Estrada MD, Herdman M, Serra-Sutton V, Tebe C, Izaguirre J, Alda JA, Alonso J, Riley AW, Forrest CB, Starfield B (2009) Parent-child agreement in the health related quality of life (HRQOL) of children with attention-deficit/hyperactivity disorder (ADHD): a longitudinal study. An Pediatr (Barc) 70:553–561CrossRef Rajmil L, Estrada MD, Herdman M, Serra-Sutton V, Tebe C, Izaguirre J, Alda JA, Alonso J, Riley AW, Forrest CB, Starfield B (2009) Parent-child agreement in the health related quality of life (HRQOL) of children with attention-deficit/hyperactivity disorder (ADHD): a longitudinal study. An Pediatr (Barc) 70:553–561CrossRef
44.
go back to reference Klassen AF, Miller A, Fine S (2006) Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. Child Care Health Dev 32:397–406CrossRefPubMed Klassen AF, Miller A, Fine S (2006) Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. Child Care Health Dev 32:397–406CrossRefPubMed
45.
46.
go back to reference Langley K, Fowler T, Ford T, Thapar AK, van den Bree M, Harold G, Owen MJ, O’Donovan MC, Thapar A (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235–240CrossRefPubMed Langley K, Fowler T, Ford T, Thapar AK, van den Bree M, Harold G, Owen MJ, O’Donovan MC, Thapar A (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235–240CrossRefPubMed
47.
go back to reference Kovshoff H, Williams S, Vrijens M, Danckaerts M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ (2012) The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician’s point of view. Eur Child Adolesc Psych 21:89–99CrossRef Kovshoff H, Williams S, Vrijens M, Danckaerts M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ (2012) The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician’s point of view. Eur Child Adolesc Psych 21:89–99CrossRef
48.
go back to reference MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 56:1073–1086CrossRef MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 56:1073–1086CrossRef
49.
go back to reference Nieuwesteeg A, Pouwer F, van der Kamp R, van Bakel H, Aanstoot HJ, Hartman E (2012) Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev 8:434–443CrossRefPubMed Nieuwesteeg A, Pouwer F, van der Kamp R, van Bakel H, Aanstoot HJ, Hartman E (2012) Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev 8:434–443CrossRefPubMed
Metadata
Title
Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls
Authors
David Coghill
Paul Hodgkins
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 3/2016
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-015-0728-y

Other articles of this Issue 3/2016

European Child & Adolescent Psychiatry 3/2016 Go to the issue